DXCM earnings call for the period ending December 31, 2024.

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

DexCom specializes in continuous glucose monitoring systems, primarily focusing on individuals managing diabetes. Its innovative CGM systems, like the G6 and the newer G7, offer real-time glucose ...

At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 ... Following our prepared remarks, we will open the call up for your questions. At that time, we ask analysts ...

Canaccord Genuity analyst William Plovanic maintains DexCom with a Buy and raises the price target from $99 to $103. Price Action: DXCM stock is up 6.22% at $89.32 at last check Friday.

This shift allows us to delve into its present market position and performance Current Position of DexCom With a trading volume of 4,506,895, the price of DXCM is up by 6.21%, reaching $89.31.

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full ...